Blood Group Typing Market Size To Reach $5.6 Billion By 2033

April 2026 | Report Format: Electronic (PDF)

Blood Group Typing Market Growth & Trends

The global blood group typing market size is anticipated to reach USD 5.59 billion by 2033, registering a CAGR of 11.99% from 2026 to 2033, according to a new report by Grand View Research. Factors, such as rising usage of blood group typing in forensic sciences and prenatal testing, increasing number of blood transfusions due to number of road accidents, and growing demand for blood and associated products are projected to drive the growth.

Blood group typing determines and identifies the O, A, B, and AB blood groups with the help of laboratory tests. The test is mandatory before transfusion as it enables checking compatibility of the blood types of the donor and the recipient along with determining the Rh factor. These tests are also performed to determine Hemolytic Disease of the Newborn (HDN) in pregnant women, which is anticipated to further drive the growth.

The reagents & consumables dominated the product segment in 2025 and is expected to witness significant growth over the forecast period due to the increase in surgical procedures, such as organ transplantation. Factors, such as increasing use of serological fluids and reagents in laboratories and high blood donation rates are anticipated to further fuel the segment growth.

North America held the largest share of the global blood group typing market in 2025. Asia Pacific is anticipated to register the fastest CAGR during the forecast period. Lack of awareness, proper blood service infrastructure, and skilled professionals, as well as the risk of transmissible diseases such as HIV and hepatitis B are some of the factors that may impede the growth of the market for blood group typing.


key Request a free sample copy or view report summary: Blood Group Typing Market Report


Blood Group Typing Market Report Highlights

  • PCR-based and microarray-based technique segment dominated the market with the largest revenue share in 2025, due to increasing R&D activities focused on antibody-antigen interactions coupled with high prevalence of chronic diseases.

  • The reagents & consumables segment held the largest market share in 2025 among the products due to increase in number of transfusions and surgical procedures involving organ transplants.

  • Asia Pacific is projected to exhibit the fastest CAGR during the forecast period, attributed to the factors such as rising per capita healthcare expenditure, prevalence of chronic diseases, and improving healthcare infrastructure.

  • The diagnostic testing segment dominated the blood group typing market, supported by the broad requirement for accurate blood-group determination, confirmatory testing, and resolution of complex or discrepant blood-group profiles across clinical laboratory workflows.

  • Diagnostic laboratories accounted for the largest revenue share of the blood group typing market in 2025, supported by their broad role in routine, confirmatory, and specialized blood-group testing for patients and transfusion services.

Blood Group Typing Market Segmentation

Grand View Research has segmented the global blood group typing market report based on the product, techniques, test type, application, end-use, and region:

Blood Group Typing Product Outlook (Revenue, USD Million, 2021 - 2033)

  • Reagents & Consumables

    • RBC reagents

    • Antisera reagents

    • Anti Human Globulin Reagents

    • Blood Saline Reagents

  • Instruments

  • Services

Blood Group Typing Techniques Outlook (Revenue, USD Million, 2021 - 2033)

  • PCR-based and Microarray Techniques

  • Assay-based Techniques

  • Massively Parallel Sequencing Techniques

  • Other Techniques

Blood Group Typing Test Type Outlook (Revenue, USD Million, 2021 - 2033)

  • Antibody Screening

  • HLA Typing

  • Cross-matching Tests

  • ABO Blood Tests

  • Antigen Typing

Blood Group Typing Application Outlook (Revenue, USD Million, 2021 - 2033)

  • Blood transfusions

  • Organ transplants

  • Diagnostic testing

Blood Group Typing End Use Outlook (Revenue, USD Million, 2021 - 2033)

  • Hospitals & clinics

  • Diagnostic laboratories

  • Blood banks

  • Others

Blood Group Typing Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

List of Key Players in the Blood Group Typing Market

  • Grifols S.A.

  • Merck KGaA

  • Bio-Rad Laboratories, Inc.

  • Immucor, Inc

  • Novacyt Group

  • Danaher Corporation

  • Agena Bioscience, Inc.

  • Ortho Clinical Diagnostics

  • Quotient, Ltd.

gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We offer custom report options, including stand-alone sections and country-level data. Special pricing is available for start-ups and universities.

Request Customization